Northwire Canada EditionFriday, July 10, 2026
Northwire
NNX 0.035 +0.0% ABX 51.79 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.12 +11.2% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.43 +0.0% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.79 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.12 +11.2% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.43 +0.0% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.390 +1.3% WMS 0.040 +0.0%
M&A / Property Routine +

Restart Life Sciences Appoints Inez Ho as Chief Financial Officer

Restart Life Sciences Taps CFO to Steer Holy Crap Foods' North American Expansion and Omnichannel Push

Executive Summary
  • Restart Life Sciences Corp. appointed Inez Ho as Chief Financial Officer, effective immediately, succeeding Rebecca Hudson.
  • The appointment is positioned to support internal restructuring, optimize newly secured purchase order (PO) financing, and manage the financial architecture for an expanding omnichannel pipeline.
  • The release highlights material commercial milestones for its subsidiary, Holy Crap Foods Inc., including surpassing 500,000 units sold, a launch on Walmart Canada's digital marketplace, and a planned U.S. market entry via Amazon Logistics.
  • A new functional protein SKU is nearing commercialization.
  • This news directly follows and confirms previously announced operational milestones: the May 21 PO financing close, the May 15 brand relaunch update, the May 13 U.S. Amazon entry announcement, the April 28 Walmart Canada launch, and the April 23 500,000 units sold milestone.
Material Impact
  • The June 3 announcement is a routine positive follow-up to a series of operational updates already disclosed over the past two months.
  • The CFO appointment is a standard scaling measure for a company managing multiple e-commerce channels and a new acquisition. It does not introduce new strategic direction or unexpected catalysts.
  • The highlighted milestones (500k units, Walmart/Amazon expansion, new SKU) were already priced in or explicitly announced in prior releases. The market has already digested the progression from acquisition (Feb) to sales tracking (April) to channel expansion (May).
  • No material deviation from previous expectations. The news reinforces management's execution but lacks the novelty required to move the stock significantly.
HEAL · Price
Company Overview
  • Restart Life Sciences Corp. is a Canadian health and wellness company transitioning from a research-focused entity to a commercial CPG operator.
  • Flagship Project: Holy Crap Foods Inc., acquired in February 2026 for $1M cash. The brand focuses on gut health, high-fiber, clean-label cereals and oatmeal.
  • The acquisition included a turnkey manufacturing facility in Gibsons, BC, retail relationships across 800+ Canadian locations, and an established e-commerce presence.
  • Pipeline: Cognitive health products (BrainQ, BrainBalls) and a new functional protein SKU under development in collaboration with the University of Manitoba's RCFTR.
  • Strategy: Omnichannel expansion leveraging Amazon, Walmart, and direct-to-consumer channels, supported by a "rapid-recycling" PO financing model to manage CPG cash flow cycles.
Read the original news release →

More from Restart Life Sciences Corp.